CLINICAL_TRIALS
trial_result
· 2018-11-16
Clinical Trial Update: Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 mechanistic study of GSK3196165 plus methotrexate in active rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2018-11-16